key: cord-0953458-yopvo3gd
authors: Yu, Y.; Gu, T.; Valley, T. S.; Fritsche, L. G.; Mukherjee, B.
title: Changes in COVID-19-related outcomes and the impacts of the potential risk factors over time: a follow-up analysis
date: 2021-01-04
journal: nan
DOI: 10.1101/2021.01.02.21249140
sha: d651687c2e205f4f5fd7a4a867c32e1c4de7f883
doc_id: 953458
cord_uid: yopvo3gd

Importance: Characteristics of COVID-19 patients changed over the course of the pandemic. Understanding how risk factors changed over time can enhance the coordination of healthcare resources and protect the vulnerable. Objective: To investigate the overall trend of severe COVID-19-related outcomes over time since the start of the pandemic, and to evaluate whether the impacts of potential risk factors, such as race/ethnic groups, changed over time. Design: This retrospective cohort study included patients tested or treated for COVID-19 at Michigan Medicine (MM) from March 10, 2020, to September 2, 2020. According to the quarter in which they first tested positive, the COVID-19-positive cohort were stratified into three groups: Q1, March 1, 2020 - March 31, 2020; Q2, April 1, 2020 - June 30, 2020; Q3, July 1, 2020 - September 2, 2020. Settings: Large, academic medical center. Participants: Individuals tested or treated for COVID-19. Exposure: Examined potential risk factors included age, race/ethnicity, smoking status, alcohol consumption, comorbidities, body mass index (BMI), and residential-level socioeconomic characteristics. Main Outcomes and Measures: The main outcomes included COVID-19-related hospitalization, intensive care unit (ICU) admission, and mortality, which were identified from the electronic health records from MM. Results: The study cohort consisted of 53,853 patients tested or treated for COVID-19 at MM, with mean (SD) age of 44.8 (23.1), mean (SD) BMI of 29.1 (7.6), and 23,814 (44.2%) males. Among the 2,582 patients who tested positive, 719 (27.8%) were hospitalized, 377 (14.6%) were admitted to ICU, and 129 (5.0%) died. The overall COVID-positive hospitalization rate decreased from 41.5% in Q1 to 12.6% in Q3, and the overall ICU admission rate decreased from 24.5% to 5.3%. Black patients had significantly higher (unadjusted) overall hospitalization rate (265 [41.1%] vs 326 [23.2%]), ICU admission rate (139 [21.6%] vs 172 [12.2%]), and mortality rate (42 [6.5%] vs 56 [4.0%]) than White patients. Each quarter, the hospitalization rate remained higher for Black patients compared to White patients, but this difference was attenuated over time for the (unadjusted) odds ratios (Q1: OR=1.9, 95% CI [1.25, 2.90]; Q2: OR=1.42, 95% CI [1.02, 1.98]; Q3: OR=1.36, 95% CI [0.67, 2.65]). Similar decreasing patterns were observed for ICU admission and mortality. Adjusting for age, sex, socioeconomic status, and comorbidity score, the racial disparities in hospitalization between White and Black patients were not significant in each quarter of the year (Q1: OR=1.43, 95% CI [0.75, 2.71]; Q2: OR=1.25, 95% CI [0.79, 1.98]; Q3: OR=1.76 95% CI [0.81, 3.85]), in contrast to what was observed in the full cohort (OR=1.85, 95% CI [1.39, 2.47]). Additionally, significant association of hospitalization with living in densely populated area was identified in the first quarter (OR= 664, 95% CI [20.4, 21600]), but such association disappeared in the second and third quarters (Q2: OR= 1.72 95% CI [0.22, 13.5]; Q3: OR=3.69, 95% CI [0.103, 132]). Underlying liver diseases were positively associated with hospitalization in White patients (OR=1.60, 95% CI [1.01, 2.55], P=.046), but not in Black patients (OR=0.49, 95% CI [0.23, 1.06], P=.072, Pint=.013). Similar results were obtained for the effect of liver diseases on ICU admission in White and Black patients (White: OR=1.75, 95% CI [1.01, 3.05], P=.047; Black: OR=0.46, 95% CI [0.17, 1.26], P=.130, Pint=.030). Conclusions and Relevance: These findings suggest that the COVID-19-related hospitalization, ICU admission, and mortality rates were decreasing over the course of the pandemic. Although racial disparities persisted, the magnitude of the differences in hospitalization and ICU admission rates diminished over time.

admitted to ICU, and 129 (5.0%) died. The overall COVID-positive hospitalization rate decreased from 41.5% in Q1 to 12.6% in Q3, and the overall ICU admission rate decreased from 24.5% to 5 Conclusions and Relevance: These findings suggest that the COVID-19-related hospitalization, ICU admission, and mortality rates were decreasing over the course of the pandemic. Although . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 4, 2021. ; https://doi.org/10.1101/2021.01.02.21249140 doi: medRxiv preprint racial disparities persisted, the magnitude of the differences in hospitalization and ICU admission rates diminished over time.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 4, 2021.

Since the World Health Organization declared coronavirus disease 2019 (COVID-19) a pandemic on March 11, 2020, 1 there have been over 77.1 million confirmed cases worldwide, including 1.70 million deaths in the following eight months. 2 The United States has surpassed 10 million cases, with the state of Michigan topping 496,000 confirmed cases and over 12,000 deaths as of December 21, 2020. 3 Studies find that racial and ethnic minority groups were disproportionately affected by COVID-19. [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] For example, higher incidence of confirmed cases, 5, 6, 8, 12 increased risk of hospitalization 6, 7, 9, 13 and greater fatality burden 5, 8, 10, 11 were identified for Black individuals when compared to White individuals. Besides known racial health disparities that impact the severity of COVID-19 outcomes, our previous study found risk factors, such as cumulative comorbidity burden, to affect outcomes in White and Black patients differently. 9 Emerging evidence shows an appreciable decline in mortality rate among patients with severe COVID-19 outcomes after the initial wave in March and April. 14-16 A recent study conducted in a single health system in New York City found that the hospital mortality rate dropped from 25.6% at the start of the pandemic in March to 7.6% by mid-August 2020, adjusting for demographic and clinical factors. 15 The same trend of improved survival over time was seen among COVID-19 patients requiring hospitalization 16 or critical care management 14 in England. Racial and ethnic disparities still remain, but recent data showed reduced differences in age-adjusted case fatality rate across ethnic groups. 17 However, the dynamics of influencing risk factors on the change of COVID-19 outcomes over time remain widely unknown. Understanding how risk . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted January 4, 2021. ; https://doi.org/10.1101/2021.01.02.21249140 doi: medRxiv preprint factors changed over the course of the pandemic can enhance the coordination of healthcare resources and protect the vulnerable.

As an follow-up of the work of Gu et al., 9 this study aims to examine the sociodemographic and clinical characteristics that are associated with various COVID-19 outcomes by race/ethnicity in an expanded COVID-19 cohort, as well as to characterize the risk factor trajectory over time, using electronic health records (EHRs) from Michigan Medicine (MM), a large academic health care system in the State of Michigan.

The study sample consisted of 53,853 patients tested or treated for COVID-19 at MM, the University of Michigan Health System, from March 10, 2020, to September 2, 2020, with 2,582 testing positive. The sample was not randomly selected, as MM prioritized testing to those with COVID symptoms or at greatest risk of exposure, particularly during the early stages of the pandemic. Patients in the tested cohort received one of the four types of diagnostic tests: an in- . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted January 4, 2021. ; https://doi.org/10.1101/2021.01.02.21249140 doi: medRxiv preprint

In this study, we focused on three different COVID-19-related outcomes among individuals who have tested positive: hospitalization, intensive unit care (ICU) admission, and mortality, which roughly represent various stages of disease progression. We also investigated the factors associated with being tested and testing positive for COVID-19 using a randomly selected untested comparison group (eMethod in the Supplement). The corresponding results are reported in the Supplement. The definitions of these COVID-19 outcomes are listed in eTable 1, and the sample sizes for each outcome are presented in eFigure 1 in the Supplement.

We followed the same process described in Gu et al. 9 to extract the relevant variables from the EHRs. The socio-demographic variables considered included age, self-reported sex, race/ethnicity, smoking status, alcohol consumption, body mass index (BMI), neighborhood socioeconomic disadvantage index (NDI), 18 and population density (in persons per square mile). 18 To characterize the underlying medical conditions of the patients, we considered seven comorbid conditions: respiratory conditions, circulatory conditions, any cancer, type 2 diabetes, kidney diseases, and autoimmune diseases, all of which were coded binary. The general health status of patients was represented by a comorbidity score ranging from 0 to 7 that sums up the aforementioned seven conditions. In addition, those who had at least one encounter in any of the primary care locations in MM since January 1, 2018, were regarded as seeking primary care.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted January 4, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted January 4, 2021. To evaluate the effect of race/ethnicity on the potential risk factors, we fit a set of models with interactions by race:

For each model, we report the Firth's bias-corrected estimates of odds ratios along with their associated 95% Wald confidence intervals (CI) and P-values. For the interaction models, we also obtained the P-values of the differences in subgroup effects for White and Black patients by testing the null hypothesis ߚ ௧ ൌ 0

. All analyses were performed using complete cases in R statistical software version 3.6.2 (R Project for Statistical Computing). proportions of patients of age65 increased over time among those who have been tested . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 4, 2021. were admitted to ICU, and 129 (5.0%) died. Older patients, male sex, ever smokers, and increased comorbidity burden tended to be associated with worsened disease severity among COVID-19-positive patients. From Q1 to Q3, the mean and median age in general decreased over time for patients who were hospitalized or admitted to ICU. We observed a greater percentage of Black than White patients among those who were hospitalized or admitted to ICU patients in Q1. However, this relationship reversed in Q2 and Q3. The overall hospitalization rate among patients testing positive decreased from 41.5% in Q1 to . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 4, 2021. 

Overall, male sex, higher BMI, ever smoker, alcohol consumption, Black patients, lower NDI, areas with higher population densities, accumulation of comorbidities were associated with an increased chance of getting tested. These associations were fairly consistent over quarters (eTable 6).

Among the patients who tested positive for COVID-19 through September 2, 2020, Black patients had significantly higher (covariate adjusted) odds of being hospitalized compared to White patients (OR=1.85, 95% CI [1.39, 2.47]). The differences in ICU admission (OR=1.33, 95%

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 4, 2021. (Figure 1) . Every 10-year increase in age, male sex, living in densely populated areas or disadvantaged neighborhoods, and heavier overall comorbidity burden were positively associated with hospitalization, ICU admission, and mortality ( Table 2) .

The racial disparities in hospitalization were not significant in each quarter of the year (Q1: . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 4, 2021. ; https://doi.org/10.1101/2021.01.02.21249140 doi: medRxiv preprint

In this study, we evaluated the potential risk factors for COVID-19 prognosis using a larger cohort from the same healthcare system that covered a longer time frame than Gu et al. 9 We observed that patients in racial minority group and with higher comorbidity burden were more susceptible to COVID-19 and more likely to be hospitalized, a result consistent with previous studies in the literature. On the other hand, the association between every 10-year increase in age and positive test results reversed compared to what was reported in Gu et al., 9 such that younger people, especially those aged 18-35 years, were more likely to be tested positive. The finding aligns with the recent data from Centers for Disease Control and Prevention, which shows an increase in the COVID-19 incidence in persons aged <30 years and a decrease in the median age for confirmed cases during May-August 2020. 19 We observed a decline in the overall hospitalization and ICU admission rates over time, which may be partly explained by the rapid increase in testing from Q1 to Q3. The analysis stratified by quarters suggests less obvious contrast in COVID-19 outcomes between Black and White patients over time. Additionally, there was a reduction in socioeconomic disparity with regard to severe COVID-19 outcomes, as the socioeconomic variables NDI and population density were in general not significantly associated with hospitalization and ICU-admission in the second and the third quarter.

A large fraction (n=169 [23.5%]) of patients who were hospitalized in our sample was transferred from external hospitals, mainly from the Detroit Metro area. These transferred . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 4, 2021. However, a sensitivity analysis that excluded patients who do not receive their primary care at Michigan Medicine was consistent with the overall analysis, namely improved outcomes and reduced health disparities over time (eFigure 8).

Our findings suggest that the COVID-19-related hospitalization, ICU admission, and mortality rates were decreasing over the course of the pandemic. Although racial disparities persisted, the magnitude of the differences in hospitalization and ICU admission rates diminished over time.

This study also identifies a number of potential risk factors for COVID-19-related outcomes: older adults, male sex, racial minority groups, those with preexisting conditions, and those with poorer socioeconomic status. Our results can be useful for vaccine prioritization after the vaccines for COVID-19 becomes available.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 4, 2021. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 4, 2021. ; https://doi.org/10.1101/2021.01.02.21249140 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 4, 2021. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 4, 2021. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 4, 2021. ; https://doi.org/10.1101/2021.01.02.21249140 doi: medRxiv preprint CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 4, 2021. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 4, 2021. ;

Abbreviations: COVID-19, coronavirus disease 2019; ICU, intensive care unit; OR, odds ratio; Q1, March 10, 2020, to March 31, 2020; Q2, April 1, 2020, to June 30, 2020; Q3, July 1, 2020, to Sep 2, 2020. + Logistic regression with Firth's correction. a Multivariable logistic regression with adjustment 1 (age + sex + race/ethnicity). Population density was also adjusted in the susceptibility (i.e. having positive test results) models. b Multivariable logistic regression with adjustment 2 (adjustment 1 + Neighborhood Socioeconomics Disadvantage Index). c Multivariable logistic regression with adjustment 3 (adjustment 2 + comorbidity score). Full Cohort Q1 Q3 Q2

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 4, 2021. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted January 4, 2021. ; https://doi.org/10.1101/2021.01.02.21249140 doi: medRxiv preprint

WHO Declares COVID-19 a Pandemic

Johns Hopkins Coronavirus Resource Center

COVID-19 and Racial/Ethnic Disparities

Assessing differential impacts of COVID-19 on black communities

Racial Disparities in Incidence and Outcomes Among Patients With COVID-19

Patients In A Large Health Care System In California

COVID-19 disparity among racial and ethnic minorities in the US: A cross sectional analysis

Characteristics Associated With Racial/Ethnic Disparities in COVID-19 Outcomes in an Academic Health Care System

Factors Associated with COVID-Related Mortality: the Case of Texas. J Racial and Ethnic Health Disparities

Racial Disparities-Associated COVID-19 Mortality among Minority Populations in the US

Disparities in Incidence of COVID-19 Among Underrepresented Racial/Ethnic Groups in Counties Identified as Hotspots During

Race/ethnicity association with COVID-19 outcomes in rheumatic disease: Data from the COVID-19 Global Rheumatology Alliance Physician Registry. Arthritis Rheumatol

Improving Survival of Critical Care Patients With Coronavirus Disease 2019 in England: A National Cohort Study

Trends in COVID-19 Risk-Adjusted Mortality Rates

Covid-19: Continued outbreaks in care homes risk extending pandemic, say experts

Deaths among COVID Cases in the United States: Racial and Ethnic Disparities Persist. medRxiv